Virax Biolabs Group Ltd Increase Decrease Through Exercise Of Warrants Equity
Virax Biolabs Group Ltd (VRAX) reported Increase Decrease Through Exercise Of Warrants Equity of $786.74 thousand for the 12-month period ending 2025-03-31, per its 20-F filed 2025-07-02.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity · last filed 2025-07-02
| Period end | Increase Decrease Through Exercise Of Warrants Equity 12 month |
|---|---|
| 2025-03-31 | $786.74K 20-F · filed 2025-07-02 |
| 2024-03-31 | $1.87M 20-F · filed 2025-07-02 |